MacroGenics Inc. common stock, trading under the NASDAQ ticker symbol MGNX, is valued at approximately $4.05 per share. Intraday price movements shift dynamically throughout active trading hours based on shifting market volume, biotechnology sector sentiment, institutional portfolio rebalancing, and periodic updates concerning the company's clinical pipeline execution and financial cash runway status.